Clinical Trial Update: A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an investigational drug (0653A-071) for mixed hyperlipidemia has completed; the study enrolled patients with hyperlipidemia,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• 0653A-071

Snippet

Sponsor: Organon and Co | Conditions: Hyperlipidemia, Hypercholesterolemia | Phase 3 | Status: COMPLETED